75589-2
LaboratoryFetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Definition
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
LOINC 6-Axis Classification
Component
Fetal Angelman syndrome risk
Property
Likelihood
Time Aspect
Pt
System
WBC.DNA+Plas.cfDNA
Scale Type
Nar
Method Type
Dosage of chromosome specific cf DNA
Details
Class
MOLPATH
Order/Observation
Both
Short Name
Fet AS risk WBC.DNA+cfDNA
Display Name
Angelman syndrome risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
Related Names
Frequently Asked Questions
What is LOINC code 75589-2?
LOINC code 75589-2 identifies "Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative". This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions. It represents the risk based on a priori risk combined with the Panorama test result.
What does 75589-2 measure?
This code measures Fetal Angelman syndrome risk in WBC.DNA+Plas.cfDNA. It belongs to the MOLPATH class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.